Portela Margareth Crisóstomo, Lotrowska Michel
Departamento de Administração e Planejamento em Saúde, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rua Leopoldo Bulhões 1480 sala 724, Manguinhos, 21041-210 Rio de Janeiro, RJ, Brazil.
Rev Saude Publica. 2006 Apr;40 Suppl:70-9. doi: 10.1590/s0034-89102006000800010. Epub 2006 May 22.
This study was intended to assess care provided to those living with HIV/AIDS in Brazil and the Brazilian Unified Health System (SUS) capacity of delivering interventions to cope with the epidemic as well as to discuss the sustainability of the Brazilian initiative of providing universal free access to antiretrovirals (ARVs). Original data from a study comprising 119 respondents on the potential capacity of delivering a prospective HIV vaccine in Brazil was used. Inpatient and pharmaceutical care was based on data from the SUS Hospital Information System and Drug Logistics Management Systems of the National Program for STD/AIDS. The study results indicate good performance of the Brazilian ARV Access Program but access to treatment of opportunistic infections was, however, unsatisfactory. The rates covered by SUS for AIDS hospital admissions remained very low, on average around R$700 in 2004. Health care to HIV/AIDS patients has been considered a citizen's right strongly supported by an effective joint action of the Brazilian government and civil society. The current challenges are fine monitoring of processes and program results and ensuring sustainability of universal free ARV access.
本研究旨在评估巴西为艾滋病毒/艾滋病感染者提供的护理，以及巴西统一卫生系统（SUS）开展应对该流行病干预措施的能力，并讨论巴西提供普遍免费抗逆转录病毒药物（ARV）倡议的可持续性。使用了一项研究的原始数据，该研究包含119名受访者关于巴西未来艾滋病毒疫苗潜在交付能力的情况。住院和药物护理基于SUS医院信息系统以及国家性传播疾病/艾滋病项目药物物流管理系统的数据。研究结果表明巴西抗逆转录病毒药物获取计划表现良好，但机会性感染的治疗获取情况却不尽人意。2004年，SUS覆盖的艾滋病住院费用率仍然很低，平均约为700雷亚尔。为艾滋病毒/艾滋病患者提供医疗保健被视为一项公民权利，得到了巴西政府和民间社会有效联合行动的大力支持。当前的挑战是对流程和项目结果进行精细监测，并确保普遍免费获取抗逆转录病毒药物的可持续性。
